BackInnate Pharma Overview

Innate Pharma Total Assets

Track Innate Pharma's total assets ($35M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$34.71M
↓ 62.65% YoYΔ $-58.23M vs prior year quarter

Peer trimmed avg / median

Loading

Innate Pharma Total Assets History

Loading

Innate Pharma vs. peers: Total Assets Comparison

Loading

Innate Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Innate Pharma (IPHA) FAQ

Innate Pharma (IPHA) currently reports a total assets of $35M as of June 2026. That compares with $93M in the prior-year period — down 62.7% year over year. Use the charts on this page to explore Innate Pharma's total assets history and peer comparisons.

Innate Pharma's total assets decreased from $93M to $35M — a 62.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Innate Pharma reported $35M in total assets as of June 2026. That compares with $93M in the prior-year period — down 62.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Innate Pharma, and consider following IPHA for alerts when major investors trade the stock.

Innate Pharma is classified in the Healthcare sector. On total assets, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IPHA with unrelated industries.